Customs tariff code 30: PHARMACEUTICAL PRODUCTS
Reference data as at 1 July 2026
Customs tariff code 30 covers PHARMACEUTICAL PRODUCTS. TARIC holds no third-country duty rate of its own for this code; the rate follows from the declarable commodity code beneath it.
30 is a chapter in the EU customs tariff. This page shows the full classification path, the duty rate, the official comparison cases, and the notes that govern this code.
This code is not declarable on its own. A declaration needs one of the subdivisions beneath it.
- Customs code
- 30
- Third-country duty
- See subdivision
- Declarable
- No
- Binding rulings
- 0
Duty rates and preferences
| Origin | Duty rate | Basis |
|---|---|---|
| Faroe Islands | 0 % | Tariff preference |
| Melilla | 0 % | Tariff preference |
| Türkiye | 0 % | Customs Union Duty |
| Andorra | 0 % | Customs Union Duty |
| San Marino | 0 % | Customs Union Duty |
| EU-Switzerland agreement: re-imported goods | 0 % | Tariff preference |
| OCTs (Overseas Countries and Territories) | 0 % | Tariff preference |
| United Kingdom | 0 % | Tariff preference |
| Tunisia | 0 % | Tariff preference |
| Morocco | 0 % | Tariff preference |
| Lebanon | 0 % | Tariff preference |
| Jordan | 0 % | Tariff preference |
Rates from the EU TARIC database. Preferential rates require valid proof of origin.
Binding tariff information for this code
The EBTI database currently holds no valid binding tariff information for this code. Comparable cases are found through the parent heading.
Notes that govern this classification
Official excerpts are reproduced in their original language.
1. Zu Kapitel 30 gehören nicht: a) Nahrungsmittel oder Getränke (wie diätetische, diabetische oder angereicherte Lebensmittel, Nahrungsergänzungsmittel, tonische Getränke und Mineralwasser), andere nicht intravenös zu verabreichende Nährstoffzubereitungen (Abschnitt IV) (RV E3001A00); b) Nikotinhaltige Erzeugnisse wie Tabletten, Kaugummis oder Pflaster (transdermale Systeme), zur Unterstützung bei der Raucherentwöhnung (Position 2404) (RV E3001B00); c) besonders gebrannter oder fein gemahlener Gips, von der in der Zahnheilkunde verwendeten Art (Position 2520) (RV E3001C00); d) destillierte aromatische Wässer und wässrige Lösungen ätherischer Öle, von der für medizinische Zwecke verwendeten Art (Position 3301) (RV E3001D00); e) Zubereitungen der Positionen 3303 bis 3307, auch mit therapeutischen oder prophylaktischen Eigenschaften (RV E3001E00); f) Seifen oder andere Erzeugnisse der Posit …
1. A) Erzeugnisse (ausgenommen radioaktive Erze), die der Warenbeschreibung der Position 2844 oder 2845 entsprechen, gehören zu diesen Positionen, auch wenn andere Positionen der Nomenklatur in Betracht kommen (RV C0601A00). B) Vorbehaltlich des Buchstabens A) gehören Erzeugnisse, die der Warenbeschreibung der Position 2843, 2846 oder 2852 entsprechen, zu diesen Positionen, auch wenn andere Positionen dieses Abschnitts in Betracht kommen (RV C0601B00). 2. Vorbehaltlich der Anmerkung 1 sind Waren, die wegen ihrer Dosierung oder wegen ihrer Aufmachung für den Einzelverkauf zu einer der Positionen 3004, 3005, 3006, 3212, 3303, 3304, 3305, 3306, 3307, 3506, 3707 oder 3808 gehören können, dieser Position zuzuweisen, auch wenn andere Positionen der Nomenklatur in Betracht kommen (RV C0602000). 3. …
Subdivisions of this code
- 3001Glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included
- 3002Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified
- 3003Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 3004Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 3005Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes
- 3006Pharmaceutical goods specified in note 4 to this chapter
Frequently asked questions
What does customs tariff code 30 cover?
Code 30 covers PHARMACEUTICAL PRODUCTS. Classification turns on the material, function, and intended use of the goods, not on their trade name.
What is the duty rate for 30?
TARIC holds no third-country rate of its own for 30. The rate follows from the declarable commodity code beneath it.
How many digits does 30 have?
30 has two digits and identifies a Harmonised System chapter. A German import declaration requires the eleven-digit commodity code.
Is there binding tariff information for 30?
The EBTI database currently holds no valid decisions on 30. Comparable cases are found through the parent heading instead.
What happens if the customs tariff code is wrong?
An incorrect code leads to post-clearance recovery of duty and import VAT, delays at clearance, and a penalty where it repeats. A classification with documented reasoning can be defended in an audit.
Does customs tariff code 30 change?
30 is currently valid. The Combined Nomenclature is amended every 1 January, so master data should be checked against the current tariff annually.
Classifying more than one product?
This page shows one code. Zolltarif-Finder classifies entire product lists from Excel, CSV, or your ERP, with reasoning under GRI 1 to 6, official sources, compliance screening, and audit-ready reports.